Net sales reached SEK 3.13 million for the 18-month period, with net loss reduced by 23.5% to SEK -7.53 million. Regulatory approval in China, new patents, and expanded distributor agreements marked significant progress, while a stable financial position supports continued international growth.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.